LAWRENCE, Mass., Jan. 4, 2011 /PRNewswire/ — NxStage Medical,
Inc. (Nasdaq:
NXTM), a leading manufacturer of innovative dialysis products,
today announced that Jeffrey H. Burbank, Chief Executive Officer
and Robert S. Brown, Chief Financial Officer, will present at the
29th Annual J.P. Morgan Healthcare Conference on Wednesday, January
12, 2011 at 11:30 a.m. (PST).
The live webcast of NxStage’s presentation and accompanying
slides will be made available at http://www.nxstage.com/ir.cfm
at the time of the presentation.
About NxStage MedicalNxStage Medical, Inc. (Nasdaq:
NXTM) is a medical device company, headquartered in Lawrence,
Massachusetts, USA, that develops, manufactures and markets
innovative products for the treatment of end-stage renal disease,
or ESRD, and acute kidney failure. For more information on NxStage
and its products, please visit the company’s website at http://www.nxstage.com.
Forward-Looking StatementsThis release contains
“forward-looking statements” within the meaning of the Private
Securities Litigation Reform Act of 1995. All statements contained
in this release that are not clearly historical in nature are
forward-looking, and the words “anticipate,” “believe,” “expect,”
“estimate,” “plan,” and similar expressions are generally intended
to identify forward-looking statements. Examples of these
forward-looking statements include statements as to Messrs. Burbank
and Brown’s plans to present at this conference. NxStage
specifically disclaims any obligation to update these
forward-looking statements. These forward-looking statements should
not be relied upon as representing NxStage’s expectations or
beliefs as of any date subsequent to the date of this press
‘/>”/>
